ArticlebioRxiv : the preprint server for biology2026
Entrenchment of germline amino-acid differences in antibody affinity maturation.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Entrenchment - epistasis that locks in amino acid differences between homologous proteins, so each disfavors substitutions toward the other's state - has been demonstrated along individual protein lineages over deep evolutionary time. Antibodies offer a unique system for studying entrenchment: multiple homologous germline V gene paralogs provide diverse starting points, and the rapid somatic evolution of affinity maturation generates dense phylogenies from which selection on germline-encoded residues can be inferred. Using DASM, a deep-learning model that separates selection from mutation in antibody repertoire data, we test for entrenchment across immunoglobulin heavy chain variable (IGHV) genes. We detect entrenchment at two levels of germline divergence, driven by different sources of epistasis. Within V gene families (up to ~20% amino acid divergence), entrenched sites cluster at the borders of the complementarity-determining regions (CDRs, the antigen-binding loops) and show high germline diversity. These sites contact antigen, light chain, and the heavy chain CDR3 loop, all of which are encoded independently of the IGHV germline. This pattern is consistent with epistasis from genetically uncoupled partners. Between V gene families, at deeper levels of divergence (25-40%), entrenchment additionally includes positions in the framework scaffold distant from binding interfaces, suggesting a larger contribution from intra-heavy-chain structural constraints. Observed mutation frequencies in human repertoires corroborate these predictions where data are sufficient. Together, these results demonstrate that the rapid somatic evolution of antibodies can serve as a lens for revealing epistatic constraints acting on germline-encoded residues, including constraints imposed by genetically uncoupled partners assembled during B cell development.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.